Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Pontifax
Pontifax

Pontifax

DeepTech NativeHerzliya, IsraelActiveWebsite
Stage FocusSeed, Series A, Series B+
GeographyIsrael, US, Europe
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Pontifax is one of Israel's leading life sciences venture firms, managing $800M+ across 6 funds since 2004. The team includes MDs, PhDs, and former pharmaceutical executives, providing the clinical and scientific depth needed to evaluate early-stage therapeutic programs. Notable exits include Kymera Therapeutics (IPO), BiomX (IPO), and Augmedics, with 30+ portfolio exits including 10+ IPOs and maj...

Notable Investments
K
Kymera Therapeutics
B
BiomX
A
Augmedics

Similar Funds

Abingworth

Abingworth

London, United Kingdom

DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital

Brandon Capital

Melbourne, Australia

DeepTech NativeBiotechMedTechSeedSeries A
Clal Biotechnology

Clal Biotechnology

Tel Aviv, Israel

DeepTech NativeBiotechMedTechSeedSeries A
Israel Biotech Fund

Israel Biotech Fund

Tel Aviv, Israel

DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer

Leaps by Bayer

Leverkusen, Germany

DeepTech NativeBiotechAgriTechMedTechSeedSeries A
M Ventures (Merck)

M Ventures (Merck)

Amsterdam, Netherlands

DeepTech NativeBiotechSemiconductorsAdvanced MaterialsSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.